SGK
EW icon

Steigerwald Gordon & Koch’s Edwards Lifesciences EW Stock Holding History

Steigerwald Gordon & Koch’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3K Hold
368
– – ﹤0.01% 364
2026
Q1 		$29.5K Hold
368
– – ﹤0.01% 373
2025
Q4 		$31.4K Sell
368
-23
-6% -$1.89K ﹤0.01% 380
2025
Q3 		$30.4K Buy
+391
New +$30.6K ﹤0.01% 374

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Steigerwald Gordon & Koch's EW Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Edwards Lifesciences (EW) position steady in Q2 2026 at 368 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

Steigerwald Gordon & Koch first reported a position in EW in Q3 2025 and has held it in 4 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Steigerwald Gordon & Koch held 368 shares of Edwards Lifesciences worth $33.3K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #364 holding.
  • Steigerwald Gordon & Koch first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.